Enveda Biosciences has 4 close competitors: Atomwise, Life Biosciences, Formation Bio.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Enveda Biosciences
Atomwise
Life Biosciences
Formation Bio
Colossal Biosciences- Home - Platform - Pipeline - Purpose - People - Careers - In-Veda TM - News - Press - Contact - Platform - Pipeline - Purpose - People - In-Veda TM - News - Press -
Enveda Biosciences competes with 4 companies here: Atomwise, Life Biosciences, Formation Bio, Colossal Biosciences.
Enveda Biosciences was last valued at $650M (post-money, Nov 2024). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $650M.
Lead investors for each round are in the funding timeline.
The closest ai drug discovery peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Enveda Biosciences is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
